Exploring the role of the oncology nurse in cervical cancer screening programs during times of transition
Cervical cancer remains the fourth most prevalent cancer among women worldwide, with approximately 660,000 new diagnoses and 350,000 deaths recorded in 2022. Countries with well-established preventative measures have experienced significant reductions in cervical cancer rates through vaccination and...
Saved in:
| Published in | Canadian oncology nursing journal Vol. 35; no. 1; pp. 223 - 232 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English French |
| Published |
Canada
Canadian Association of Nurses in Oncology
2025
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1181-912X 2368-8076 |
Cover
| Abstract | Cervical cancer remains the fourth most prevalent cancer among women worldwide, with approximately 660,000 new diagnoses and 350,000 deaths recorded in 2022. Countries with well-established preventative measures have experienced significant reductions in cervical cancer rates through vaccination and regular screening. In Canada, recent efforts have emphasized the adoption of primary HPV-DNA testing as a primary screening tool in cervical cancer screening programs, replacing the cytology (pap) testing. The COVID-19 pandemic had disrupted these initiatives, posing challenges to screening and vaccination programs. Despite these setbacks, ongoing recovery strategies are underway to mitigate the pandemic's adverse effects. Several challenges regarding this shift also have been identified by countries that have transitioned their respective screening programs to primary HPV-DNA testing. Understanding these unique challenges will be essential for developing strategies to address barriers, such as implementing new technologies, training healthcare providers, and ensuring equitable access to screening. This review seeks to (1) examine the evolution of HPV testing and the transition from cervical cytology (Pap smear) to HPV testing as the primary screening method; (2) assess the long-term impacts of the COVID-19 pandemic on screening, prevention, and HPV vaccination within the Canadian healthcare system; and (3) explore the pivotal role of oncology nurses in advancing education, advocacy, and leadership in cancer prevention. |
|---|---|
| AbstractList | Cervical cancer remains the fourth most prevalent cancer among women worldwide, with approximately 660,000 new diagnoses and 350,000 deaths recorded in 2022. Countries with well-established preventative measures have experienced significant reductions in cervical cancer rates through vaccination and regular screening. In Canada, recent efforts have emphasized the adoption of primary HPV-DNA testing as a primary screening tool in cervical cancer screening programs, replacing the cytology (pap) testing. The COVID-19 pandemic had disrupted these initiatives, posing challenges to screening and vaccination programs. Despite these setbacks, ongoing recovery strategies are underway to mitigate the pandemic’s adverse effects. Several challenges regarding this shift also have been identified by countries that have transitioned their respective screening programs to primary HPV-DNA testing. Understanding these unique challenges will be essential for developing strategies to address barriers, such as implementing new technologies, training healthcare providers, and ensuring equitable access to screening. This review seeks to (1) examine the evolution of HPV testing and the transition from cervical cytology (Pap smear) to HPV testing as the primary screening method; (2) assess the long-term impacts of the COVID-19 pandemic on screening, prevention, and HPV vaccination within the Canadian healthcare system; and (3) explore the pivotal role of oncology nurses in advancing education, advocacy, and leadership in cancer prevention. Cervical cancer remains the fourth most prevalent cancer among women worldwide, with approximately 660,000 new diagnoses and 350,000 deaths recorded in 2022. Countries with well-established preventative measures have experienced significant reductions in cervical cancer rates through vaccination and regular screening. In Canada, recent efforts have emphasized the adoption of primary HPV-DNA testing as a primary screening tool in cervical cancer screening programs, replacing the cytology (pap) testing. The COVID-19 pandemic had disrupted these initiatives, posing challenges to screening and vaccination programs. Despite these setbacks, ongoing recovery strategies are underway to mitigate the pandemic's adverse effects. Several challenges regarding this shift also have been identified by countries that have transitioned their respective screening programs to primary HPV-DNA testing. Understanding these unique challenges will be essential for developing strategies to address barriers, such as implementing new technologies, training healthcare providers, and ensuring equitable access to screening. This review seeks to (1) examine the evolution of HPV testing and the transition from cervical cytology (Pap smear) to HPV testing as the primary screening method; (2) assess the long-term impacts of the COVID-19 pandemic on screening, prevention, and HPV vaccination within the Canadian healthcare system; and (3) explore the pivotal role of oncology nurses in advancing education, advocacy, and leadership in cancer prevention.Cervical cancer remains the fourth most prevalent cancer among women worldwide, with approximately 660,000 new diagnoses and 350,000 deaths recorded in 2022. Countries with well-established preventative measures have experienced significant reductions in cervical cancer rates through vaccination and regular screening. In Canada, recent efforts have emphasized the adoption of primary HPV-DNA testing as a primary screening tool in cervical cancer screening programs, replacing the cytology (pap) testing. The COVID-19 pandemic had disrupted these initiatives, posing challenges to screening and vaccination programs. Despite these setbacks, ongoing recovery strategies are underway to mitigate the pandemic's adverse effects. Several challenges regarding this shift also have been identified by countries that have transitioned their respective screening programs to primary HPV-DNA testing. Understanding these unique challenges will be essential for developing strategies to address barriers, such as implementing new technologies, training healthcare providers, and ensuring equitable access to screening. This review seeks to (1) examine the evolution of HPV testing and the transition from cervical cytology (Pap smear) to HPV testing as the primary screening method; (2) assess the long-term impacts of the COVID-19 pandemic on screening, prevention, and HPV vaccination within the Canadian healthcare system; and (3) explore the pivotal role of oncology nurses in advancing education, advocacy, and leadership in cancer prevention. |
| Author | Gosselin, Sophie Lamanna, Alessia Buick, Catriona |
| Author_xml | – sequence: 1 givenname: Alessia surname: Lamanna fullname: Lamanna, Alessia organization: student, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto ON; York University, Faculty of Health, School of Nursing, Toronto, ON – sequence: 2 givenname: Sophie surname: Gosselin fullname: Gosselin, Sophie organization: Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON – sequence: 3 givenname: Catriona surname: Buick fullname: Buick, Catriona organization: Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto ON; York University, Faculty of Health, School of Nursing, Toronto, ON |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40874108$$D View this record in MEDLINE/PubMed |
| BookMark | eNpdkU1Lw0AQhhdRbK39C7LgxUtgv7LZnkRK_YCCFwVvYZNM0i3Jbtxtiv33rm0VdS4zMO88vC9zgU6ts3CCxoxLlSiSyVM0plTRZEbZ2whNQ1iTWCqlipBzNBJEZYISNUZm8dG3zhvb4M0KsHctYFfvZ2dL17pmh-3gA2BjcQl-a0rd4lLbOONQegD7ddt713jdBVwNB5bpIOxBXttgNsbZS3RW6zbA9Ngn6PV-8TJ_TJbPD0_zu2XSU0FkooAVDFQKpGB1IWmdZsBYIbUSsqhqyiotSV2AAKVoVnEgqtJZwdOqSjnjMz5BtwduPxQdVCXY6KHNe2867Xe50yb_u7FmlTdum1PGs9mMyki4ORK8ex8gbPLOhBLaVltwQ8g5E5JTrpSI0ut_0rUbvI35ck4zkcVEhEbV1W9LP16-38A_AVdAiZA |
| ContentType | Journal Article |
| Copyright | 2025 Canadian Association of Nurses in Oncology (CANO). 2025. This work is published under https://creativecommons.org/licenses/by-nc-sa/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2025 Canadian Association of Nurses in Oncology (CANO) 2025 |
| Copyright_xml | – notice: 2025 Canadian Association of Nurses in Oncology (CANO). – notice: 2025. This work is published under https://creativecommons.org/licenses/by-nc-sa/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2025 Canadian Association of Nurses in Oncology (CANO) 2025 |
| DBID | NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK 8FQ ABUWG AFKRA AN0 ASE AZQEC BENPR CCPQU COVID DWQXO FPQ FYUFA GHDGH K6X K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DatabaseName | PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest CBCA Database ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest British Nursing Database British Nursing Index ProQuest Central Essentials ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) British Nursing Index ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection CBCA Complete ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition British Nursing Index with Full Text Coronavirus Research Database British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2368-8076 |
| EndPage | 232 |
| ExternalDocumentID | PMC12379916 40874108 |
| Genre | Journal Article |
| GroupedDBID | --- 04C 6PF 7RV 7X7 88E 8FI 8FJ 8FQ AAWTL ABUWG ADBBV ADOJX AFKRA ALMA_UNASSIGNED_HOLDINGS BCNDV BENPR BKEYQ BMSDO BPHCQ BVXVI CCPQU DWQXO EBD ECF ECT EIHBH F5P FRP FYUFA HMCUK HYE M1P NAPCQ NPM OK1 PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RPM UKHRP ZT4 3V. 7XB 8FK AN0 ASE AZQEC COVID FPQ K6X K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-p1406-8e2b2e85e0b2fb61f57e22b6a846bdf12da60fbe4e8817d3e08da7b35dd532393 |
| IEDL.DBID | BENPR |
| ISSN | 1181-912X |
| IngestDate | Tue Sep 30 17:00:54 EDT 2025 Thu Oct 02 21:35:11 EDT 2025 Tue Oct 07 06:39:32 EDT 2025 Tue Sep 16 01:42:51 EDT 2025 |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English French |
| License | 2025 Canadian Association of Nurses in Oncology (CANO). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-p1406-8e2b2e85e0b2fb61f57e22b6a846bdf12da60fbe4e8817d3e08da7b35dd532393 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/3174740601?pq-origsite=%requestingapplication%&accountid=15518 |
| PMID | 40874108 |
| PQID | 3174740601 |
| PQPubID | 2041165 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_12379916 proquest_miscellaneous_3246313884 proquest_journals_3174740601 pubmed_primary_40874108 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-Winter 20250101 |
| PublicationDateYYYYMMDD | 2025-01-01 |
| PublicationDate_xml | – year: 2025 text: 2025-Winter |
| PublicationDecade | 2020 |
| PublicationPlace | Canada |
| PublicationPlace_xml | – name: Canada – name: Vancouver |
| PublicationTitle | Canadian oncology nursing journal |
| PublicationTitleAlternate | Can Oncol Nurs J |
| PublicationYear | 2025 |
| Publisher | Canadian Association of Nurses in Oncology |
| Publisher_xml | – name: Canadian Association of Nurses in Oncology |
| SSID | ssj0000851800 |
| Score | 2.319628 |
| Snippet | Cervical cancer remains the fourth most prevalent cancer among women worldwide, with approximately 660,000 new diagnoses and 350,000 deaths recorded in 2022.... |
| SourceID | pubmedcentral proquest pubmed |
| SourceType | Open Access Repository Aggregation Database Index Database |
| StartPage | 223 |
| SubjectTerms | Cellular biology Cervical cancer COVID-19 vaccines Human papillomavirus Immunization Medical screening Oncology Pandemics Supplement |
| Title | Exploring the role of the oncology nurse in cervical cancer screening programs during times of transition |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40874108 https://www.proquest.com/docview/3174740601 https://www.proquest.com/docview/3246313884 https://pubmed.ncbi.nlm.nih.gov/PMC12379916 |
| Volume | 35 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2368-8076 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000851800 issn: 1181-912X databaseCode: RPM dateStart: 20160101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2368-8076 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000851800 issn: 1181-912X databaseCode: 7X7 dateStart: 20150101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2368-8076 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000851800 issn: 1181-912X databaseCode: BENPR dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB5qC-JFfLtaSwSvi7vZR9KDiEpLEVpELPRWNpsJ9rJb-zj4782k22pFvC0kG5ZMduZL5ss3ADdtozFAjn5O3AobIdp-JkTbN0LIII9imTq2e3-Q9obx8ygZ1WCwvgtDtMq1T3SOWpc5nZHf2jgXi5jUQ-6nHz5VjaLs6rqERlaVVtB3TmJsBxqclLHq0HjsDF5eN6cuBDCku5dCFy7tn85Hf0HL3wzJHyGnewD7FVZkDyvjHkINiyPY7VfZ8GOYbAh0zMI4RkRBVhr3XBZOjfqTOZIGmxQsd07BDpeTnWfMugu7haV3K4rWnK2uLDJXbt4NRHHMUbpOYNjtvD31_Kp0gj-1O6bUl8gVR5lgoLhRaWgSgZyrNLNwQ2kTcp2lgVEYo5Sh0BEGUmdCRYnWSUSqaKdQL8oCz4EZtBhOp6g5Gsoatg1GmcyUUMZuX0LuQXM9f-Nq_c_H39by4HrTbFcupSOyAsul7cPjNAojKWMPzlbTPZ6uJDbGcSAt1AmkB3LLEJsOpIq93VJM3p06tg3FgkDvxf_fdQl7nEr5utOUJtQXsyVeWXyxUC3YESPRqpbOFxGM1oU |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB71IVEuiBZol7bUSHCMSBwndg4Vgj60fewKoVbaW4jjsbqXZOm2Qv1z_LbOeLMLRRW33iI5sSJ7PPON55sZgA-FdxijxKhmbgVZiCKqtC4ir7WJ61SZPLDdB8O8f6lOR9loCX7Pc2GYVjnXiUFRu7bmO_JPZOeUVlw95PPkZ8Rdozi6Om-hUXWtFdx-KDHWJXac4d0vcuGm-yeHtN8fpTw-ujjoR12XgWhCzkUeGZRWoskwttLbPPGZRiltXpFlts4n0lV57C0qNCbRLsXYuErbNHMuS7mAGM27DKsqVQU5f6tfj4bfvi9ueRjQmJAHwwmepFnk6DEo-y8j8y8Td_wSXnTYVHyZCdM6LGGzAc8GXfT9FYwXhD1BsFEwMVG0Pjy3Tah-fScCKUSMG1EHJUTT1SxX14LUE7nM_G1HCZuKWYqkCO3tw0RsNwOF7DVcPskivoGVpm1wC4RHwowuRyfRc5Sy8JhWprLaenKXEtmDnfn6ld15m5Z_pKMH7xfDdFI4_FE12N7SO1LlaZIao3qwOVvucjIr6VGq2BC0ik0PzIONWLzAVbgfjjTjq1CNm0y_ZpD99v__tQdr_YvBeXl-MjzbhueS2wiHm5wdWLm5vsVdwjY39l0nQAJ-PLXM3gNyjBMX |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exploring+the+role+of+the+oncology+nurse+in+cervical+cancer+screening+programs+during+times+of+transition&rft.jtitle=Canadian+oncology+nursing+journal&rft.au=Lamanna%2C+Alessia&rft.au=Gosselin%2C+Sophie&rft.au=Buick%2C+Catriona&rft.date=2025-01-01&rft.pub=Canadian+Association+of+Nurses+in+Oncology&rft.issn=1181-912X&rft.eissn=2368-8076&rft.volume=35&rft.issue=1&rft.spage=223 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1181-912X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1181-912X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1181-912X&client=summon |